Come up with a name for your new list and we'll add to it:
PhotoPharmics raised a round of funding on February 10, 2017. Investors include
Kickstart Seed Fund.
PhotoPharmics provides specialized phototherapy which allows dopamine to be assimilated by Parkinson's patients. A number of trials, including a 4-year, 130 patient study, demonstrate dramatic symptom…